KP Tissue (KPTSF) Financial Statements
KP Tissue Financial Overview
KP Tissue's market cap is currently $83.89M. The company's EPS TTM is $0.89; its P/E ratio is 13.13; and it has a dividend yield of 6.64%. KP Tissue is estimated to report earnings on November 11, 2026, and the estimated EPS forecast is $0.21. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| EBITDA | $ 318.23M | $ 264.78M | $ 239.64M | $ 116.74M | $ 153.75M |
| Net Income | $ 8.50M | $ 2.43M | $ -4.94M | $ -10.25M | $ 1.24M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Total Assets | $ 71.60M | $ 71.31M | $ 70.61M | $ 81.71M | $ 80.72M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Total Liabilities | $ 1.80M | $ 1.80M | $ 2.25M | $ 7.68M | $ 4.85M |
| Stockholders' Equity | $ 69.80M | $ 69.52M | $ 68.36M | $ 74.03M | $ 75.87M |
| Cash Flow | |||||
| Free Cash Flow | $ 0.00 | $ 6.97M | $ 6.98M | $ 6.62M | $ 1.15M |
| Operating Cash Flow | $ 0.00 | $ 6.97M | $ 6.98M | $ 6.62M | $ 1.15M |
| Investing Cash Flow | $ 6.96M | $ 6.97M | $ 6.98M | $ 6.62M | $ 5.56M |
| Financing Cash Flow | $ -6.96M | $ -6.97M | $ -6.98M | $ -6.62M | $ -5.56M |
Currency in CAD